Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Gastroenterology|September 19, 2017
Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NETIBD)Jana Langbrandtner, Angelika Hüppe, Petra Jessen, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|May 6, 2020
Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization StatementHelmut Neumann, Fabian Emura, Bernd Bokemeyer, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 2, 2009
[Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner]Jan C Preiss, Bernd Bokemeyer, Britta Siegmund, et al.
International Journal of Colorectal Disease|May 8, 2021
Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-StudyRomina di Giuseppe, Sandra Plachta-Danielzik, Wolfgang Mohl, et al.
Digestion|January 23, 2026
Quality of Care and Burden in Patients with Celiac Disease: Results from the German Celiac Registry (GeCeR)Sibylle Koletzko, Christina Sobotzki, Margit Blömacher, et al.
Inflammatory Bowel Diseases|December 30, 2014
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial programChristoph Gasche, Tariq Ahmad, Zsolt Tulassay, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2026
Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in GermanyArne Bokemeyer, Florian Tran, Sandra Plachta-Danielzik, et al.
International Journal of Colorectal Disease|August 26, 2019
Predictive parameters for the clinical course of Crohn's disease: development of a simple and reliable risk modelAndreas Stallmach, Bernd Bokemeyer, Ulf Helwig, et al.
Zeitschrift Fur Gastroenterologie|August 14, 2018
[Ustekinumab - Current position]Britta Siegmund, Christoph Högenauer, Gottfried Novacek, et al.
Inflammatory Bowel Diseases|April 22, 2024
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS StudyWolfgang Kruis, Bernd Bokemeyer, Petra Jessen, et al.
Pageof 8